Chemoinformaics analysis of Alkannin-beta-hydroxyisovalerate
Molecular Weight | 388.416 | nRot | 6 |
Heavy Atom Molecular Weight | 364.224 | nRig | 14 |
Exact Molecular Weight | 388.152 | nRing | 2 |
Solubility: LogS | -3.271 | nHRing | 0 |
Solubility: LogP | 4.378 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
nHA | 7 | APOL | 56.687 |
nHD | 3 | BPOL | 28.417 |
QED | 0.229 |
Synth | 3.474 |
Natural Product Likeliness | 1.399 |
NR-PPAR-gamma | 0.303 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.004 |
Pgp-sub | 0.554 |
HIA | 0.927 |
CACO-2 | -5.025 |
MDCK | 0.0000234 |
BBB | 0.004 |
PPB | 0.977524 |
VDSS | 0.612 |
FU | 0.0684921 |
CYP1A2-inh | 0.927 |
CYP1A2-sub | 0.361 |
CYP2c19-inh | 0.281 |
CYP2c19-sub | 0.058 |
CYP2c9-inh | 0.768 |
CYP2c9-sub | 0.893 |
CYP2d6-inh | 0.645 |
CYP2d6-sub | 0.307 |
CYP3a4-inh | 0.102 |
CYP3a4-sub | 0.149 |
CL | 6.4 |
T12 | 0.896 |
hERG | 0.002 |
Ames | 0.647 |
ROA | 0.153 |
SkinSen | 0.924 |
Carcinogencity | 0.209 |
EI | 0.894 |
Respiratory | 0.124 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.650963 |